Stock Screener · Library
REGENERON PHARMACEUTICALS, INC. financial statement history
Source-linked financial facts for REGENERON PHARMACEUTICALS, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 25434800000 | USD | 2023-02-06 | 2022 / FY | us-gaap:Assets | 10-K · 0001804220-23-000008 |
| As of 2022-12-31 | 29214500000 | USD | 2024-02-05 | 2023 / FY | us-gaap:Assets | 10-K · 0001804220-24-000009 |
| As of 2023-12-31 | 33080200000 | USD | 2025-02-05 | 2024 / FY | us-gaap:Assets | 10-K · 0001804220-25-000011 |
| As of 2024-12-31 | 37759400000 | USD | 2026-02-04 | 2025 / FY | us-gaap:Assets | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 40558700000 | USD | 2026-02-04 | 2025 / FY | us-gaap:Assets | 10-K · 0000872589-26-000008 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 14014900000 | USD | 2023-02-06 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001804220-23-000008 |
| As of 2022-12-31 | 15884100000 | USD | 2024-02-05 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001804220-24-000009 |
| As of 2023-12-31 | 19479200000 | USD | 2025-02-05 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001804220-25-000011 |
| As of 2024-12-31 | 18660900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 18021900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0000872589-26-000008 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 2885600000 | USD | 2024-02-05 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001804220-24-000009 |
| As of 2022-12-31 | 3105900000 | USD | 2025-02-05 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001804220-25-000011 |
| As of 2023-12-31 | 2730000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000872589-26-000008 |
| As of 2024-12-31 | 2488200000 | USD | 2026-02-04 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 3118100000 | USD | 2026-02-04 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000872589-26-000008 |
Inventory
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 1951300000 | USD | 2023-02-06 | 2022 / FY | us-gaap:InventoryNet | 10-K · 0001804220-23-000008 |
| As of 2022-12-31 | 2401900000 | USD | 2024-02-05 | 2023 / FY | us-gaap:InventoryNet | 10-K · 0001804220-24-000009 |
| As of 2023-12-31 | 2580500000 | USD | 2025-02-05 | 2024 / FY | us-gaap:InventoryNet | 10-K · 0001804220-25-000011 |
| As of 2024-12-31 | 3087300000 | USD | 2026-02-04 | 2025 / FY | us-gaap:InventoryNet | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 3200800000 | USD | 2026-02-04 | 2025 / FY | us-gaap:InventoryNet | 10-K · 0000872589-26-000008 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 6666000000 | USD | 2023-02-06 | 2022 / FY | us-gaap:Liabilities | 10-K · 0001804220-23-000008 |
| As of 2022-12-31 | 6550500000 | USD | 2024-02-05 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001804220-24-000009 |
| As of 2023-12-31 | 7107100000 | USD | 2025-02-05 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001804220-25-000011 |
| As of 2024-12-31 | 8405800000 | USD | 2026-02-04 | 2025 / FY | us-gaap:Liabilities | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 9301800000 | USD | 2026-02-04 | 2025 / FY | us-gaap:Liabilities | 10-K · 0000872589-26-000008 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 3932500000 | USD | 2023-02-06 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001804220-23-000008 |
| As of 2022-12-31 | 3141300000 | USD | 2024-02-05 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001804220-24-000009 |
| As of 2023-12-31 | 3423400000 | USD | 2025-02-05 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001804220-25-000011 |
| As of 2024-12-31 | 3944300000 | USD | 2026-02-04 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 4368400000 | USD | 2026-02-04 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000872589-26-000008 |
Long-term debt
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 1980000000 | USD | 2023-02-06 | 2022 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001804220-23-000008 |
| As of 2022-12-31 | 1981400000 | USD | 2024-02-05 | 2023 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001804220-24-000009 |
| As of 2023-12-31 | 1982900000 | USD | 2025-02-05 | 2024 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001804220-25-000011 |
| As of 2024-12-31 | 1984400000 | USD | 2026-02-04 | 2025 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 1985900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0000872589-26-000008 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 18768800000 | USD | 2025-02-05 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001804220-25-000011 |
| As of 2022-12-31 | 22664000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0000872589-26-000008 |
| As of 2023-12-31 | 25973100000 | USD | 2026-02-04 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0000872589-26-000008 |
| As of 2024-12-31 | 29353600000 | USD | 2026-02-04 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0000872589-26-000008 |
| As of 2025-12-31 | 31256900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0000872589-26-000008 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 16071700000 | USD | 2024-02-05 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 12172900000 | USD | 2025-02-05 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 13117200000 | USD | 2026-02-04 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 14202000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 14342900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000872589-26-000008 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 2860100000 | USD | 2024-02-05 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 3592500000 | USD | 2025-02-05 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 4439000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 5132000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 5850200000 | USD | 2026-02-04 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000872589-26-000008 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 8946800000 | USD | 2024-02-05 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 4738900000 | USD | 2025-02-05 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 4047100000 | USD | 2026-02-04 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 3990700000 | USD | 2026-02-04 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 3577900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000872589-26-000008 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 8075300000 | USD | 2024-02-05 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 4338400000 | USD | 2025-02-05 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 3953600000 | USD | 2026-02-04 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 4412600000 | USD | 2026-02-04 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 4504900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0000872589-26-000008 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 71.97 | USD/shares | 2024-02-05 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 38.22 | USD/shares | 2025-02-05 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 34.77 | USD/shares | 2026-02-04 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 38.34 | USD/shares | 2026-02-04 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 41.48 | USD/shares | 2026-02-04 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000872589-26-000008 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 7081300000 | USD | 2024-02-05 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 5014900000 | USD | 2025-02-05 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 4594000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 4420500000 | USD | 2026-02-04 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 4978900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000872589-26-000008 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 551900000 | USD | 2024-02-05 | 2023 / FY | us-gaap:PaymentsToAcquireProductiveAssets | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 590100000 | USD | 2025-02-05 | 2024 / FY | us-gaap:PaymentsToAcquireProductiveAssets | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 718600000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsToAcquireProductiveAssets | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 755900000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsToAcquireProductiveAssets | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 898400000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsToAcquireProductiveAssets | 10-K · 0000872589-26-000008 |
Dividends paid
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2023-01-01 to 2023-12-31 | 0 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 370300000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsOfDividends | 10-K · 0000872589-26-000008 |
Share repurchases
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 1645400000 | USD | 2024-02-05 | 2023 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0001804220-24-000009 |
| 2022-01-01 to 2022-12-31 | 2082800000 | USD | 2025-02-05 | 2024 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0001804220-25-000011 |
| 2023-01-01 to 2023-12-31 | 2235000000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0000872589-26-000008 |
| 2024-01-01 to 2024-12-31 | 2603300000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0000872589-26-000008 |
| 2025-01-01 to 2025-12-31 | 3438600000 | USD | 2026-02-04 | 2025 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0000872589-26-000008 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 872589
- Ticker in native snapshot
- REGN
- Reported numeric facts
- 83
- Units present
- USD · USD/shares